Articles From: Our Outlook for the Stock Market to OvaScience to Present at the Oppenheimer Healthcare Conference


2013/09/25
We think stockpicking--rather than macro guessing--is the way to excess returns.
Sign-up for Our Outlook for the Stock Market investment picks
2013/12/27
A rising market leaves fewer opportunities, but stocks are still the place to be over the long run.
Sign-up for Our Outlook for the Stock Market investment picks
2009/06/24
The new BGI presents a lot of continuity for iShares and some new opportunities.
Sign-up for Our Take on iShares' New Owner: BlackRock investment picks
2010/06/10
Before you make your next move, get the right context, perspective, and insight on the European market shocks.
Sign-up for Our Take on the European Crisis investment picks
Outerwall Civic Venture Award Recognizes InvestNextDoor's Efforts to Create a New Source of Capital for Small Businesses BELLEVUE , Wash.
Sign-up for Outerwall and Points of Light Announce Inaugural Award to Drive Positive Change in Local Communities investment picks
Director Nora M.
Sign-up for Outerwall Announces Leadership Change investment picks
Redbox Remains the Best Value in Home Entertainment with Daily Rental Prices As Low As $1.50 a Day BELLEVUE, Wash.
Sign-up for Outerwall Announces New Daily Rental Prices for Redbox Movies and Video Games investment picks
2015/1/20
By Tess Stynes Outerwall Inc. on Tuesday said Chief Executive J.
Sign-up for Outerwall CEO Di Valerio steps down investment picks
Operating Margins Increased Year-over-Year and Sequentially; Redbox Signed New and Extended Existing Content Agreements; New ecoATM Retail Agreements Signed; ecoATM Installs Grew to 1,510 at Quarter End BELLEVUE, Wash.
Sign-up for Outerwall Inc. Announces 2014 Third Quarter Results investment picks
Commitment to community nonprofits builds on $91,744 already contributed during regular NFL season BELLEVUE, Wash.
Sign-up for Outerwall to Donate for each Seahawks First Down Recorded at Home During 2014 NFL Playoffs investment picks
By Kirsten Grind Investors yanked an industry record $27.5 billion from Pacific Investment Management Co.'s flagship fund last month as the surprise exit of co-founder Bill Gross took its toll on the firm he co-founded.
Sign-up for Outflows at Pimco flagship bond fund set new record investment picks
NEW YORK , Dec.
Sign-up for OUTFRONT Media Announces Details Of Special Dividend investment picks
2014/12/8
Enabling a Contemporary Digital Experience at Scale for Consumers, Advertisers, Municipal Franchisors, and Real Estate Owners NEW YORK , Dec.
Sign-up for OUTFRONT Media Partners With Videri To Introduce New Digital Display Platform investment picks
Housing Faces Upward Grind in 2015 WASHINGTON , Oct.
Sign-up for Outlook for U.S. Economic Growth Still Solid Even as Global Growth Slows investment picks
National staffing firm adopts Benefitfocus cloud-based platform to automate benefits enrollment and administration CHARLESTON, S.C. , Oct.
Sign-up for Outsource, LLC Selects Benefitfocus HR INTOUCH MARKETPLACE® investment picks
OvaScience SM (NASDAQ: OVAS), a global life sciences company focused on the discovery, development and commercialization of new fertility treatments, today announced the Company has achieved its 2014 corporate goals to advance the AUGMENT SM , OvaPrime SM and OvaTure SM treatments for patients in need of new fertility treatment options.
Sign-up for OvaScience Advances All Three Fertility Treatment Options investment picks
OvaScience SM (NASDAQ: OVAS), a global life sciences company focused on the discovery, development and commercialization of new fertility treatments, announced today the closing of its previously announced public offering of common stock, including the exercise in full by the underwriters of their option to purchase an additional 345,000 shares of common stock at the public offering price of $50.00 per share.
Sign-up for OvaScience Announces Closing of $132 Million Public Offering of Common Stock including Exercise of Underwriters’ Option to Purchase Additional Shares investment picks
OvaScience SM (NASDAQ: OVAS), a global life sciences company focused on the discovery, development and commercialization of new fertility treatments, announced today it has commenced an underwritten public offering of up to $85 million of shares of its common stock.
Sign-up for OvaScience Announces Proposed Public Offering of Common Stock investment picks
OvaScience SM (NASDAQ:OVAS), a global life sciences company focused on the discovery, development and commercialization of new fertility treatments, today reported third quarter 2014 financial results.
Sign-up for OvaScience Reports Third Quarter 2014 Financial Results investment picks
OvaScience SM (NASDAQ: OVAS), a global life sciences company focused on the discovery, development and commercialization of new fertility treatments, announced today key changes to the leadership team that will support OvaScience’s expanding global commercial operations.
Sign-up for OvaScience Strengthens Management Team to Support Expanding Global Operations investment picks
OvaScience SM (NASDAQ: OVAS), a global life sciences company focused on the discovery, development and commercialization of new fertility treatments, announced today that the Company is hosting an Investor Day on Wednesday, December 17, 2014 at the Benjamin Hotel in New York from 8:00 a.m. to approximately 11:30 a.m. ET.
Sign-up for OvaScience to Host Investor Day investment picks
OvaScience SM (NASDAQ: OVAS), a global life sciences company focused on the discovery, development and commercialization of new fertility treatments, announced today that Michelle Dipp, M.D., Ph.D., Chief Executive Officer of OvaScience, will participate in the Fortune Most Powerful Women Next Gen conference on December 3, 2014.
Sign-up for OvaScience to Participate in Fortune Most Powerful Women Next Gen Conference investment picks
OvaScience SM (NASDAQ: OVAS), a global life sciences company focused on the discovery, development and commercialization of new fertility treatments, announced today that Company management will participate in the Partnering for Cures meeting, an event convened by the Milken Institute’s FasterCures.
Sign-up for OvaScience to Participate in Partnering for Cures Conference investment picks
OvaScience SM (NASDAQ: OVAS), a global life sciences company focused on the discovery, development and commercialization of new fertility treatments, announced today that Michelle Dipp, M.D., Ph.D., Chief Executive Officer of OvaScience, will present at the 33 rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2015 at 3:30 pm local time at the Westin St.
Sign-up for OvaScience to Present at the J.P. Morgan Healthcare Conference investment picks
OvaScience SM (NASDAQ:OVAS), a global life sciences company focused on the discovery, development and commercialization of new fertility treatments, announced today that Company management will present at the Oppenheimer 25 th Annual Healthcare Conference on Thursday, December 11, 2014 at 2:10 pm ET at the Crowne Plaza Times Square hotel in New York.
Sign-up for OvaScience to Present at the Oppenheimer Healthcare Conference investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Our Outlook for the Stock Market to OvaScience to Present at the Oppenheimer Healthcare Conference
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent